Search Results 251-260 of 17100 for monoclonal antibody

1. Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma - Mayo Clinic

   Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

2. Penpulimab-kcqx (intravenous route) - Side effects & uses - Mayo Clinic

   Penpulimab-kcqx is a monoclonal antibody that changes the immune system to help control the growth of cancer cells. This medicine is to be given only by or ...

3. A Study to Evaluate Pembrolizumab, Ixazomib Citrate, and Dexamethasone to Treat Participants with Relapsed Multiple Myeloma - Mayo Clinic

   Monoclonal antibodies, such as pembrolizumab, may interfere with the ability ... antibody. Measurable disease of multiple myeloma as defined by at ...

4. Pediatric Brain Tumor Surgery Clinical Trials - Mayo Clinic Research

   Dinutuximab is a monoclonal antibody that binds to a molecule called GD2, which is found in greater than normal amounts on some types of cancer cells. This ...

5. Focus Areas - T Cell Engineering Laboratory - Mayo Clinic Research

   These include secondary modification of CAR-T cells and combination strategies with monoclonal antibodies, small molecules, peptides and other immunotherapeutic ...

6. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

   Depemokimab is a humanised, affinity matured monoclonal antibody that blocks human interleukin-5 (IL-5) binding to its receptor. Depemokimab is being ...

7. Nivolumab and Brentuximab Vedotin in Treating Older Patients With Untreated Hodgkin Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Biological therapies, such as brentuximab ...

8. 177Lu-DTPA-Omburtamab Radioimmunotherapy toTreat Recurrent or Refractory Medulloblastoma - Mayo Clinic

   The purpose of this study is to assess 177Lu-DTPA-omburtamab, which is a radioactive labelling of a murine monoclonal antibody targeting B7-H3, to treat ...

9. Clinical trials - Oncology (Medical)

   Pertuzumab and trastuzumab are monoclonal antibodies and forms of targeted therapy that attach to a receptor protein called human epidermal growth factor ...

10. Clinical trials - Oncology (Medical)

    Immunotherapy with monoclonal antibodies, such as daratumumab, may induce changes in the body's immune system and may interfere with the ability of tumor cells ...